Skip Nav Destination
A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older
Issue Archive
August 6 2009
In this Issue
Table of Contents
INSIDE BLOOD
BLOOD WORK
PLENARY PAPERS
Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments
Ilona Kryczek,Mousumi Banerjee,Pui Cheng,Linhua Vatan,Wojciech Szeliga,Shuang Wei,Emina Huang,Emily Finlayson,Diane Simeone,Theodore H. Welling,Alfred Chang,George Coukos,Rebecca Liu,Weiping Zou
REVIEW ARTICLES
HOW I TREAT
CLINICAL TRIALS AND OBSERVATIONS
A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older
Clinical Trials & Observations
Jean-Luc Harousseau,Giovanni Martinelli,Wieslaw W. Jedrzejczak,Joseph M. Brandwein,Dominique Bordessoule,Tamas Masszi,Gert J. Ossenkoppele,Julia A. Alexeeva,Gernot Beutel,Johan Maertens,Maria-Belen Vidriales,Hervé Dombret,Xavier Thomas,Alan K. Burnett,Tadeusz Robak,Nuriet K. Khuageva,Anatoly K. Golenkov,Elena Tothova,Lars Mollgard,Youn C. Park,Annick Bessems,Peter De Porre,Angela J. Howes,for the FIGHT-AML-301 Investigators
GENE THERAPY
HEMATOPOIESIS AND STEM CELLS
IMMUNOBIOLOGY
LYMPHOID NEOPLASIA
2-phenylacetylenesulfonamide (PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells
Andrew J. Steele,Archibald G. Prentice,A. Victor Hoffbrand,Birunthini C. Yogashangary,Stephen M. Hart,Mark W. Lowdell,Edward R. Samuel,Janet M. North,Elisabeth P. Nacheva,Anastasios Chanalaris,Panagiotis Kottaridis,Kate Cwynarski,R. Gitendra Wickremasinghe
Pretargeting CD45 enhances the selective delivery of radiation to hematolymphoid tissues in nonhuman primates
Damian J. Green,John M. Pagel,Eneida R. Nemecek,Yukang Lin,Aimee Kenoyer,Anastasia Pantelias,Donald K. Hamlin,D. Scott Wilbur,Darrell R. Fisher,Joseph G. Rajendran,Ajay K. Gopal,Steven I. Park,Oliver W. Press
PLATELETS AND THROMBOPOIESIS
RED CELLS, IRON, AND ERYTHROPOIESIS
TRANSPLANTATION
Protection from graft-versus-host disease by HIV-1 envelope protein gp120-mediated activation of human CD4+CD25+ regulatory T cells
Christian Becker,Christian Taube,Tobias Bopp,Christoph Becker,Kai Michel,Jan Kubach,Sebastian Reuter,Nina Dehzad,Markus F. Neurath,Kurt Reifenberg,Franz-Joseph Schneider,Edgar Schmitt,Helmut Jonuleit
VASCULAR BIOLOGY
CORRESPONDENCE
ERRATUM
-
Cover Image
Cover Image
Greinacher and colleagues demonstrate that eptifibatide induces antibodies in patients that can reduce the expression of GPIIbIIIa and the viability of megakaryocytes. This effect only occurs in the presence of eptifibatide and the GPIIbIIIa-directed antibody (compare red staining pattern in top and bottom panels). Cover art prepared by Diana Lim. See the article by Greinacher et al on page 1250.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals